NASDAQ · Financial Statements
MediciNova, Inc. (MNOV) Financial Statements
$1.52
NASDAQ: MNOV
Market Cap $74.82M
Overview Financials Dividend MediciNova, Inc. most recently reported annual revenue of $0, net profit of $-12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $4.0M $0 $1.0M $0 $0 Operating Profit $-10.0M $-15.0M $-10.0M $-13.0M $-13.0M Net Profit $-10.0M $-14.0M $-9.0M $-11.0M $-12.0M EPS $-0.21 $-0.29 $-0.17 $-0.23 $-0.24 Op Margin -253.0% — -990.0% — -3242.5%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $87.0M $74.0M $66.0M $56.0M $46.0M Total Liabilities $4.0M $4.0M $4.0M $3.0M $4.0M Cash $71.0M $19.0M $51.0M $40.0M $31.0M Borrowings $1.0M $1.0M $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-9.0M $-13.0M $-7.0M $-11.0M $-10.0M Investing Cash Flow $0 $-40.0M $40.0M $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $11.0M $-53.0M $32.0M $-11.0M $-10.0M Free Cash Flow $-9.0M $-13.0M $-7.0M $-11.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.94 EV / EBITDA -5.68 FCF Yield -2199.71% Quick Ratio 8.75 Interest Coverage 0.00 Return 1Y 10.60% Return 3Y -46.86% Return 5Y -64.11%
Screens featuring this stock